LAB

Standard BioTools Inc. Common Stock

1.26

USD

LAB Earnings Reports

Positive Surprise Ratio

LAB beat 15 of 34 last estimates.

44%

Next Report

Date of Next Report

Feb 18, 2026

Estimate for Q4 25 (Revenue/ EPS)

$18.69M

-$0.07

Implied change from Q3 25 (Revenue/ EPS)

-4.42%

-22.22%

Implied change from Q4 24 (Revenue/ EPS)

-60.00%

-22.22%

Standard BioTools Inc. Common Stock earnings per share and revenue

On Nov 04, 2025, LAB reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.05 USD, resulting in a -61.87% surprise. Revenue reached 19.55 million, compared to an expected 18.18 million, with a 7.56% difference. The market reacted with a -4.20% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 18.69 million USD, implying an decrease of -22.22% EPS, and decrease of -4.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Azenta, Inc.

Report Date

Feb 04, 2026 For Q1 26

Estimate

$0.14

Actual

$0.09

Surprise

-35.94%

Doximity, Inc.

Report Date

Feb 05, 2026 For Q3 26

Estimate

$0.45

Actual

$0.46

Surprise

+1.21%

Omnicell Inc

Report Date

Feb 05, 2026 For Q4 25

Estimate

$0.50

Actual

$0.40

Surprise

-20.98%

FAQ

What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Standard BioTools Inc. Common Stock reported EPS of -$0.09, missing estimates by -61.87%, and revenue of $19.55M, 7.56% above expectations.

How did the market react to Standard BioTools Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -4.2%, changed from $1.19 before the earnings release to $1.14 the day after.

When is Standard BioTools Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 18, 2026.

What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?

Based on 4 analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $18.69M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.